Marcel Kap
Erasmus University Rotterdam
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marcel Kap.
Journal of Proteome Research | 2010
Bilge Ergin; Stephan Meding; Rupert Langer; Marcel Kap; Christian Viertler; Christina Schott; Uta Ferch; Peter Riegman; Kurt Zatloukal; Axel Walch; Karl-Friedrich Becker
Formalin fixation and paraffin embedding is the standard technique for preserving biological material for both storage and histological analysis. Although recent progress has been made in the molecular analysis of formalin-fixed, paraffin-embedded (FFPE) tissues, proteomic applications are a special challenge due to the cross-linking property of formalin. Here we present the results of a new formalin-free tissue fixative, PAXgene, and demonstrate successful extraction of nondegraded and immunoreactive protein for subsequent standard protein assays, such as Western blot analysis and reverse-phase protein arrays. High amounts of protein can be obtained from PAXgene-fixed, paraffin-embedded (PFPE) mouse liver and human spleen, breast, duodenum, and stomach tissues, similar to frozen material. By Western blot analysis, we found that the detection of membrane, cytoplasmic, nuclear, and phosphorylated protein from PAXgene-fixed human tissue samples was comparable to cryopreserved samples. Furthermore, the distribution of protein in PAXgene-fixed human tissue specimens is adequate for matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry for in situ proteomic analysis. Taken together, we demonstrate here that PAXgene has great potential to serve as a novel multimodal fixative for modern pathology, enabling extensive protein biomarker studies on clinical tissue samples.
PLOS ONE | 2011
Marcel Kap; Frank Smedts; Wolter Oosterhuis; Rosa Winther; Nanna Christensen; Bilge Reischauer; Christian Viertler; Daniel Groelz; Karl-Friedrich Becker; Kurt Zatloukal; Rupert Langer; Julia Slotta-Huspenina; Koppany Bodo; Bas W.D. de Jong; Uwe Oelmüller; Peter Riegman
Within SPIDIA, an EC FP7 project aimed to improve pre analytic procedures, the PAXgene Tissue System (PAXgene), was designed to improve tissue quality for parallel molecular and morphological analysis. Within the SPIDIA project promising results were found in both genomic and proteomic experiments with PAXgene-fixed and paraffin embedded tissue derived biomolecules. But, for this technology to be accepted for use in both clinical and basic research, it is essential that its adequacy for preserving morphology and antigenicity is validated relative to formalin fixation. It is our aim to assess the suitability of PAXgene tissue fixation for (immuno)histological methods. Normal human tissue specimens (n = 70) were collected and divided into equal parts for fixation either with formalin or PAXgene. Sections of the obtained paraffin-embedded tissue were cut and stained. Morphological aspects of PAXgene-fixed tissue were described and also scored relative to formalin-fixed tissue. Performance of PAXgene-fixed tissue in immunohistochemical and in situ hybridization assays was also assessed relative to the corresponding formalin-fixed tissues. Morphology of PAXgene-fixed paraffin embedded tissue was well preserved and deemed adequate for diagnostics in most cases. Some antigens in PAXgene-fixed and paraffin embedded sections were detectable without the need for antigen retrieval, while others were detected using standard, formalin fixation based, immunohistochemistry protocols. Comparable results were obtained with in situ hybridization and histochemical stains. Basically all assessed histological techniques were found to be applicable to PAXgene-fixed and paraffin embedded tissue. In general results obtained with PAXgene-fixed tissue are comparable to those of formalin-fixed tissue. Compromises made in morphology can be called minor compared to the advantages in the molecular pathology possibilities.
Journal of Proteome Research | 2012
Sibylle Gündisch; Stefanie M. Hauck; Hakan Sarioglu; Christina Schott; Christian Viertler; Marcel Kap; Tibor Schuster; Bilge Reischauer; Robert D. Rosenberg; Cornelis Verhoef; Hans-Joerg Mischinger; Peter Riegman; Kurt Zatloukal; Karl-Friedrich Becker
The quality of human tissue specimens can have a significant impact on analytical data sets for biomarker research. The aim of this study was to characterize fluctuations of protein and phosphoprotein levels in human tissue samples during the preanalytical phase. Eleven intestine and 17 liver specimens were surgically resected, aliquoted, and either snap-frozen or fixed in formalin immediately or exposed to different ischemic conditions before preservation. Protein levels in the resultant samples were investigated by reverse phase protein array, Western blot analysis, and liquid chromatography-tandem mass spectrometry. Our data revealed that the degree of sensitivity of proteins and phosphoproteins to delayed preservation varied between different patients and tissue types. For example, up-regulation of phospho-p42/44 MAPK in intestine samples was seen in some patients but not in others. General trends toward up- or down-regulation of most proteins were not evident due to pronounced interpatient variability but signal intensities of only a few proteins, such as cytokeratin 18, were altered from baseline in postresection samples. In contrast, glyceraldehyde 3-phosphate dehydrogenase was found to be stable during periods of cold ischemia. Our study represents a proper approach for studying potential protein fluctuations in tissue specimens for future biomarker development programs.
PLOS ONE | 2014
Anita van der Linden; Britt M. Blokker; Marcel Kap; Annick C. Weustink; Peter Riegman; J. Wolter Oosterhuis
Introduction Bereaved relatives often refuse to give consent for post-mortem investigation of deceased cancer patients, mainly because of the mutilation due to conventional autopsy (CA). Minimally invasive autopsy (MIA) may be a more acceptable alternative and, if implemented in clinical practice, creates an opportunity to more often obtain post-mortem tissue samples of (recurred) primary tumors and metastases for molecular research. As a measure for tissue quality for molecular studies, we hereby present a feasibility study, comparing the RNA quality of MIA and CA samples, and fresh frozen samples as reference. Materials and methods Tissue samples of heart, liver and kidney were prospectively collected from 24 MIAs followed by CA, and compared to corresponding archival fresh frozen tissue. After RNA isolation and RT-qPCR, RNA integrity numbers (RIN) and GAPDH expression (six amplicon sizes ranging from 71 to 530 base pairs) were measured. RIN values and GAPDH Cq values were analyzed and compared between all sample groups and post-mortem intervals (PMI). Results RIN values in MIA samples were significantly higher than those in CA samples. GAPDH was expressed significantly higher in MIA samples than in CA samples and 530 bp PCR products could be measured in all cases. GAPDH expression was significantly lower in samples with PMI >15 hours. As expected, the samples of the fresh frozen reference standard performed best in all analyses. Conclusion MIA samples showed better RNA quality than CA samples, probably due to shorter PMI. Both had lower RNA quality and expression levels than fresh frozen tissue, however, remaining GAPDH RNA was still sufficiently intact. Therefore, other highly expressed genes are most likely also detectable. Gene array analysis should be performed to gain insight into the quality of entire post-mortem genomes. Reducing PMI will further improve the feasibility of demanding molecular research on post-mortem tissues, this is most likely more feasible with MIA than CA.
Biopreservation and Biobanking | 2013
Marcel Kap; Georgina I. Arron; Martina Loibner; Anja Hausleitner; Gintare Siaulyte; Kurt Zatloukal; Jean-Luc Murk; Peter Riegman
Formalin fixation is known to inactivate most viruses in a vaccine production context, but nothing is published about virus activity in tissues treated with alternative, non-crosslinking fixatives. We used a model assay based on cell culture to test formalin and PAXgene Tissue fixative for their virus-inactivating abilities. MDCK, A549, and MRC-5 cells were infected with Influenza A virus, Adenovirus, and Cytomegalovirus, respectively. When 75% of the cells showed a cytopathic effect (CPE), the cells were harvested and incubated for 15 min, or 1, 3, 6, or 24 hours, with PBS (positive control), 4% formalin, or PAXgene Tissue Fix. The cells were disrupted and the released virus was used to infect fresh MDCK, A549, and MRC-5 cells cultured on cover slips in 24-well plates. The viral cultures were monitored for CPE and by immunocytochemistry (ICC) to record viral replication and infectivity. Inactivation of Adenovirus by formalin occurred after 3 h, while Influenza A virus as well as Cytomegalovirus were inactivated by formalin after 15 min. All three virus strains were inactivated by PAXgene Tissue fixative after 15 min. We conclude that PAXgene Tissue fixative is at least as effective as formalin in inactivating infectivity of Influenza A virus, Adenovirus, and Cytomegalovirus.
Histopathology | 2015
Marcel Kap; King H. Lam; Patricia C. Ewing-Graham; Peter Riegman
Cold ischaemic and formalin fixation time (CIT and FFT) are considered to be crucial parameters for intralaboratory variation in immunohistochemistry (IHC). Here we describe a new method to optimize IHC, by using control tissue blocks with known pre‐analytical history and comparing the IHC outcome with digitized reference slides.
Liver Transplantation | 2003
Michiel C. Warlé; Ayar Farhan; Herold J. Metselaar; Wim C. J. Hop; Chris Perrey; Pieter E. Zondervan; Marcel Kap; Jaap Kwekkeboom; Jan N. M. IJzermans; Hugo W. Tilanus; Vera Pravica; Ian V. Hutchinson; Gerda J. Bouma
Liver Transplantation | 2002
Michiel C. Warlé; Ayar Farhan; Herold J. Metselaar; Wim C. J. Hop; Chris Perrey; Pieter E. Zondervan; Marcel Kap; Sjoerd de Rave; Jaap Kwekkeboom; Jan N. M. IJzermans; Hugo W. Tilanus; Vera Pravica; Ian V. Hutchinson; Gerda J. Bouma
Human Immunology | 2001
Michiel C. Warlé; Ayar Farhan; Herold J. Metselaar; Wim C. J. Hop; Arnout J. van der Plas; Marcel Kap; Sjoerd de Rave; Jaap Kwekkeboom; Pieter E. Zondervan; Jan N. M. IJzermans; Hugo W. Tilanus; Vera Pravica; Ian V. Hutchinson; Gerda J. Bouma
Journal of Proteome Research | 2013
Stefano Cacciatore; Xiaoyu Hu; Christian Viertler; Marcel Kap; Gerwin A. Bernhardt; Hans-Jörg Mischinger; Peter Riegman; Kurt Zatloukal; Claudio Luchinat; Paola Turano